CDK9 Inhibitors in Acute Myeloid Leukemia

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-018-0704-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

Acute Myeloid Leukemia

JAMA - Journal of the American Medical Association
Medicine
2010English

Acute Myeloid Leukemia

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Progress in Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia

Cancer Research
Cancer ResearchOncology
2015English

The Evolving Role of FLT3 Inhibitors in Acute Myeloid Leukemia: Quizartinib and Beyond

Therapeutic Advances in Hematology
Hematology
2014English

SALL1 Expression in Acute Myeloid Leukemia

Oncotarget
Oncology
2017English

Novel Agents in Acute Myeloid Leukemia

International Journal of Hematology
Hematology
2012English

Methylation Profiling in Acute Myeloid Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy